home / stock / bior / bior quote
Last: | $0.7161 |
---|---|
Change Percent: | -1.03% |
Open: | $0.748 |
Close: | $0.7161 |
High: | $0.7495 |
Low: | $0.715 |
Volume: | 132,916 |
Last Trade Date Time: | 05/08/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$0.7161 | $0.748 | $0.7161 | $0.7495 | $0.715 | 132,916 | 05-08-2024 |
$0.7404 | $0.76 | $0.7404 | $0.76 | $0.73 | 114,565 | 05-07-2024 |
$0.7513 | $0.7489 | $0.7513 | $0.7698 | $0.7181 | 268,608 | 05-06-2024 |
$0.731 | $0.7 | $0.731 | $0.748 | $0.67 | 269,185 | 05-03-2024 |
$0.7128 | $0.642 | $0.7128 | $0.72 | $0.631 | 427,801 | 05-02-2024 |
$0.642 | $0.649 | $0.642 | $0.6545 | $0.6225 | 287,635 | 05-01-2024 |
$0.6554 | $0.639 | $0.6554 | $0.66 | $0.62 | 254,907 | 04-30-2024 |
$0.6225 | $0.625 | $0.6225 | $0.6396 | $0.612 | 128,041 | 04-29-2024 |
$0.6277 | $0.6334 | $0.6277 | $0.6334 | $0.6018 | 133,686 | 04-26-2024 |
$0.607 | $0.611 | $0.607 | $0.632001 | $0.5999 | 151,521 | 04-25-2024 |
$0.6199 | $0.639 | $0.6199 | $0.65 | $0.6 | 183,432 | 04-24-2024 |
$0.639 | $0.63 | $0.639 | $0.6609 | $0.615 | 382,433 | 04-23-2024 |
$0.6061 | $0.601 | $0.6061 | $0.613 | $0.5928 | 160,218 | 04-22-2024 |
$0.615 | $0.6 | $0.615 | $0.62 | $0.6 | 105,736 | 04-19-2024 |
$0.5995 | $0.65 | $0.5995 | $0.679 | $0.585 | 519,543 | 04-18-2024 |
$0.6421 | $0.64 | $0.6421 | $0.67 | $0.62 | 317,789 | 04-17-2024 |
$0.621 | $0.61 | $0.621 | $0.65 | $0.6099 | 244,168 | 04-16-2024 |
$0.62 | $0.6733 | $0.62 | $0.6733 | $0.61 | 452,759 | 04-15-2024 |
$0.671 | $0.6902 | $0.671 | $0.7 | $0.661 | 300,071 | 04-12-2024 |
$0.7049 | $0.69 | $0.7049 | $0.714999 | $0.6805 | 162,808 | 04-11-2024 |
News, Short Squeeze, Breakout and More Instantly...
Biora Therapeutics Inc. Company Name:
BIOR Stock Symbol:
NASDAQ Market:
SAN DIEGO, May 07, 2024 (GLOBE NEWSWIRE) -- Biora Therapeutics, Inc . (Nasdaq: BIOR), the biotech company that is reimagining therapeutic delivery, today announced it will report financial results and provide a corporate update for the first quarter ended March 31, 2024. The company’s ...
SAN DIEGO, May 06, 2024 (GLOBE NEWSWIRE) -- Biora Therapeutics, Inc . (Nasdaq: BIOR), the biotech company that is reimagining therapeutic delivery, today announced that it will present clinical data on device function of the NaviCap™ Targeted Oral Delivery Platform at Digestive Disease...
Dosing of all patients in the trial has been successfully completed Final results are expected to be available in late Q2 2024 SAN DIEGO, April 30, 2024 (GLOBE NEWSWIRE) -- Biora Therapeutics, Inc . (Nasdaq: BIOR), the biotech company that is reimagining therapeutic delivery, ...